Search for Clinical Trial Results

Sponsored By

Malignant Mixed Mullerian Tumor - 25 Studies Found

Status Study
Completed Study Name: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus
Condition: Mixed Tumor, Mullerian
Date: 2007-07-16
Interventions:
  • Drug: Carboplatin AUC 5 By Vei
Completed Study Name: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
Condition: Uterine Carcinosarcoma
Date: 2008-05-28
Interventions:
  • Drug: paclitaxel Paclitaxel wi
Not yet recruiting Study Name: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Condition:
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Date: 2016-12-01
    Interventions: Drug: Trabectedin Other Name: Yondelis
Not yet recruiting Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas
Date: 2014-05-05
Interventions:
  • Drug: Pazopanib plus Gemcitabine

Completed Study Name: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
Condition: Mixed Mullerian Tumors of the Uterus
Date: 2007-05-17
Interventions:
  • Drug: Gemcitabine Other Name:

Completed Study Name: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
Condition:
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
    • Date: 2001-10-11
    Interventions:
    • Other: Laboratory Biomarker Analysis

Completed Study Name: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Condition:
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
    • Date: 2010-11-23
    Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names:
Active, not recruiting Study Name: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Condition:
  • Recurrent Uterine Sarcoma
  • Uterine Carcinosarcoma

Date: 2010-07-22
Interventions:
  • Drug: ixabepilone Given IV
Terminated Study Name: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Condition:
  • Recurrent Uterine Sarcoma
  • Uterine Carcinosarcoma

Date: 2010-02-02
Interventions: Drug: temsirolimus Given IV Other Names:
Completed Study Name: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Condition:
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
    • Date: 2005-06-13
    Interventions:
    • Drug: Gemcitabine Hydrochloride

Next >>>